drugset / Trial / NCT01208922
Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to prove the non-inferiority of Rifamycin SV-MMX® versus Ciprofloxacin for the treatment of adults with traveller's diarrhoea.
Timeline
- Start
- 2010-11
- Primary completion
- 2016-01
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ciprofloxacin | Small molecule | 500 mg | Oral |
| Subject | Rifamycin SV MMX | Unknown | 400 mg | Oral |